| Literature DB >> 22545723 |
Chinyere O Mbachu1, Obinna E Onwujekwe, Benjamin S C Uzochukwu, Eloka Uchegbu, Joseph Oranuba, Amobi L Ilika.
Abstract
BACKGROUND: In order to achieve universal health coverage, the government of Anambra State, southeast Nigeria has distributed free Long-lasting Insecticide treated Nets (LLINs) to the general population and delivered free Artemisinin-based Combination Therapy (ACT) to pregnant women and children less than 5 years. However, the levels of coverage with LLINS and ACTs is not clear, especially coverage of different socio-economic status (SES) population groups. This study was carried out to determine the level of coverage and access to LLINs and ACTs amongst different SES groups.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22545723 PMCID: PMC3358243 DOI: 10.1186/1471-2458-12-315
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Flowchart showing sample selection process from local government areas to households.
Socio-demographic characteristics of respondents
| Sex | |
| ·Females | 2112 (88) |
| ·Males | 287 (12) |
| Age (years) | |
| ·15–24 | 313(13.1) |
| ·25–34 | 1347(56.2) |
| ·35–44 | 600(25.1) |
| ·45–54 | 106(4.4) |
| ·55–64 | 24(1.0) |
| ·65–74 | 5(0.2) |
| Mean Age (years) = 31.8(SD 7.3) | |
| Number of pregnant women | 898(37.1) |
| Mean Gestational Age (months) = 2.1(SD 2.9) | |
| Number of households with at least one child ≪5 years | 2300 (95.8) |
| Number of households with no child ≪5 years old | 101(4.2) |
| No. of People in Households (N = 2397) | |
| ·≪5 | 808(33.6) |
| ·5–10 | 1574(65.6) |
| ·>10 | 19(0.8) |
Ownership and utilization of LLINs by members of households and reasons for non-utilization
| Variables | Proportions |
|---|---|
| Number of households that have a LLIN | 1932 (80.5) |
| | |
| Number of households where a LLIN was used the previous night | 1244 (64.4) |
| Number of households in which a LLIN was used the previous night by: (N1 = 1244) | |
| ·All household members | 784 (63.0) |
| ·Pregnant women only | 83 (6.7) |
| ·Children under five years only | 377 (30.3) |
| Reasons for non-use of LLINs by households (N2 = 688) | |
| ·Forgot to use it | 21 (3.1) |
| ·Makes me sweat | 454 (66.0) |
| ·Not necessary | 43 (6.3) |
| ·Mosquitoes still bite me | 51 (7.5) |
| ·Skin irritation | 65 (9.4) |
| ·Other reasons | 65 (9.4) |
N1 represents number of households where a long-lasting insecticide treated net was used the previous night which is 1244 households.
N2 represents number of households where a long-lasting insecticide treated net was not used the previous night, which is 688 households.
Drugs used in primary health care facilities for treatment of malaria in pregnant women and children less than five years
| Drugs used for treatment of malaria | Proportion of people treated |
|---|---|
| | |
| Artemisinin-based combination therapy (ACT) | 174 (45.7) |
| Chloroquine | 1 (0.4) |
| Quinine | 8 (2.2) |
| Sulphadoxine-Pyrimethamine (SP) | 129 (33.9) |
| Artesunate monotherapy (AM) | 4 (1.1) |
| Others | 64 (16.7) |
| | |
| Artemisinin-based combination therapy | 324 (38.7) |
| Chloroquine | 127 (15.2) |
| Quinine | 27 (3.2) |
| Sulphadoxine-Pyrimethamine | 86 (10.2) |
| Artesunate monotherapy | 28 (3.3) |
| Others | 246 (29.4) |
Others include herbal medicines and concoctions; unknown mixture of tablets and injections; paracetamol; and paludrine.
Socioeconomic differences in the ownership and source of LLINs
| Variables | Q1 n(%) | Q2 n(%) | Q3 n(%) | Q4 n(%) | Q5 n(%) | Q1:Q5 (equity ratio) | Chi square ( |
|---|---|---|---|---|---|---|---|
| 365(78) | 388(83) | 393(84) | 380(81) | 359(77) | 1.02 | 12.38(0.15) | |
| | | | | | | | |
| 1–5 | 362(99.2) | 385(99) | 389(99) | 369(97) | 344(96) | 1.05 | |
| >5 | 3(0.8) | 3(1) | 4(1) | 11(3) | 15(4) | 0.15 | 157.29(0.0) |
| | | | | | | | |
| During immunization | 38 (11) | 56 (14) | 70 (18) | 60 (18) | 79(21) | 0.52 | 15.92(0.003) |
| Antenatal clinics | 79 (22) | 78 (20) | 88 (22) | 60 (18) | 67(18) | 1.22 | 7.78(0.100) |
| Free distribution | 288 (78) | 295 (75) | 313 (80) | 330 (87) | 304(89) | 0.98 | 17.21(0.002) |
| Purchased LLIN | 13(4) | 3 (1) | 15 (4) | 10 (3) | 19(5) | 0.80 | 12.78(0.012) |
| Others | 6 (1.7) | 1 (0.3) | 4 (1) | 4 (1) | 1(0.3) | 5.67 | 6.53(0.160) |
Socioeconomic differences in the utilization of antimalarials by pregnant women
| Antimalarials used for treatment of fever | Q1 (%) | Q2 (%) | Q3 (%) | Q4 (%) | Q5 (%) | Q1:Q5 | Chi square ( |
|---|---|---|---|---|---|---|---|
| | | | | | | | |
| ACTs | 9(28) | 13(29) | 13(33) | 29(43) | 27(26) | 1.1 | 5.97(0.20) |
| Chloroquine | 0(0) | 1(2) | 0(0) | 0(0) | 2(2) | 0 | 2.85(0.58) |
| Quinine | 0(0) | 0(0) | 1(2.6) | 1(1.5) | 1(1) | 0 | 1.83(0.77) |
| Sulfadoxine-pyrimethamine | 7(21) | 11(24) | 8(21) | 13(19) | 22(21) | 1 | 0.42(0.98) |
| Artesunate monotherapy | 1(3) | 2(4) | 5(13) | 4(6) | 9(9) | 0.3 | 3.69(0.45) |
| Others | 5(15) | 4(9) | 7(18) | 7(10) | 6(6) | 2.5 | 5.61(0.23) |
| | | | | | | | |
| ACTs | 10(27) | 16(28) | 15(34) | 36(48) | 42(38) | 0.71 | 7.66(0.11) |
| Chloroquine | 0(0) | 0(0) | 0(0) | 0(0) | 1(1) | 0.0 | 1.94(0.75) |
| Quinine | 1(3) | 0(0) | 1(2.3) | 1(1.3) | 2(2) | 1.49 | 1.45(0.84) |
| Sulfadoxine-pyrimethamine | 10(27) | 21(37) | 14(32) | 16(21) | 30(27) | 0.99 | 4.21(0.38) |
| Artesunate monotherapy | 0(0) | 1(2) | 0(0) | 1(1) | 1(1) | 0.0 | 1.32(0.86) |
| Others | 10(27) | 5(9) | 11(25) | 12(16) | 6(5) | 4.95 | 18.09(0.001) |